Submission Details
| 510(k) Number | K223103 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 30, 2022 |
| Decision Date | June 20, 2023 |
| Days to Decision | 263 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K223103 is an FDA 510(k) clearance for the BethaLoc? stem cementless HA, a Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (Class II — Special Controls, product code LZO), submitted by Implantcast GmbH (Buxtehude, DE). The FDA issued a Cleared decision on June 20, 2023, 263 days after receiving the submission on September 30, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3353.
| 510(k) Number | K223103 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 30, 2022 |
| Decision Date | June 20, 2023 |
| Days to Decision | 263 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | LZO — Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3353 |